| Name | N'-(pyridin-2-yl)picolinohydrazide |
|---|---|
| Synonyms | MFCD27925103 |
| Description | PFI-90 is a selective inhibitor of histone demethylase (KDM3B) that inhibits PAX3-FOXO1 action. PFI-90 induces apoptosis and myogenic differentiation, resulting in the cell death increased. PFI-90 has the potential for the antitumor activity. (patent WO2021101929A1). |
|---|---|
| Related Catalog | |
| Target |
IC50: 812 nM (RH4); 3200 nM (RH30); 1895 nM (OSA-CL); 1113 nM (TC-32)[1] |
| In Vitro | PFI-90 shows dose response in RH4, RH30, OSA-CL and TC-32 cells, with IC50s of 812, 3200, 1895 and 1113 nM, respectively[1]. PFI-90 (3 μΜ; 24 hours) increases apoptosis in RH4 and SCMC cells[1]. Western Blot Analysis[1] Cell Line: RH4 and SCMC cells Concentration: 3 μΜ Incubation Time: 24 hours Result: Apoptosis increased in RH4 and SCMC cells. |
| References |
| Molecular Formula | C11H10N4O |
|---|---|
| Molecular Weight | 214.22300 |
| Exact Mass | 214.08500 |
| PSA | 66.91000 |
| LogP | 1.69740 |
| Hazard Codes | Xi |
|---|
| Precursor 0 | |
|---|---|
| DownStream 1 | |